Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by BigShoes13on Jan 09, 2014 8:05pm

91 Views

Post# 22076354

RE:Common Sense

Stock

We generally post when we disagree about things, but I have to say I agree with most of what you say.

I defnitely agree that 90% (or more) of the venture companies are POC (piec of cr*p) and a total waste of time.

That is why even with SBM, I take a "show me" attidtue.

However, that being said it looks like we are on the right track and things look promising.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading